{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:43:02Z","timestamp":1791571382171,"version":"4.3.4"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 RR024156"],"award-info":[{"award-number":["UL1 RR024156"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 DK083256"],"award-info":[{"award-number":["T32 DK083256"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR000040"],"award-info":[{"award-number":["UL1 TR000040"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009560","name":"American Gastroenterological Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006474","name":"Columbia University","doi-asserted-by":"publisher","award":["U54 CA 163004"],"award-info":[{"award-number":["U54 CA 163004"]}],"id":[{"id":"10.13039\/100006474","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.cll.2014.08.008","type":"journal-article","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T16:22:21Z","timestamp":1411575741000},"page":"771-785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":171,"title":["The Impact of Proton Pump Inhibitors on the Human Gastrointestinal Microbiome"],"prefix":"10.1016","volume":"34","author":[{"given":"Daniel E.","family":"Freedberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian A.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2014.08.008_bib1","first-page":"147","article-title":"Les pH des selles des nourrissons sains et malades","volume":"19","author":"Dorlencourt","year":"1931","journal-title":"Nourrisson"},{"issue":"8","key":"10.1016\/j.cll.2014.08.008_bib2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.29.8.1035","article-title":"Measurement of gastrointestinal pH profiles in normal ambulant human subjects","volume":"29","author":"Evans","year":"1988","journal-title":"Gut"},{"issue":"24","key":"10.1016\/j.cll.2014.08.008_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJM194812092392402","article-title":"Observations on the etiologic relationship of achylia gastrica to pernicious anemia; activity of vitamin B12 as food, extrinsic factor","volume":"239","author":"Berk","year":"1948","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.cll.2014.08.008_bib4","first-page":"183","article-title":"Intraluminal pH of the human gastrointestinal tract","volume":"46","author":"Fallingborg","year":"1999","journal-title":"Dan Med Bull"},{"issue":"5","key":"10.1016\/j.cll.2014.08.008_bib5","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/0016-5085(88)90366-6","article-title":"Biotin transport in the human intestine: site of maximum transport and effect of pH","volume":"95","author":"Said","year":"1988","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0005-2736(79)90022-1","article-title":"Enzymatic reduction and methylation of folate following pH-dependent, carrier-mediated transport in rat jejunum","volume":"554","author":"Strum","year":"1979","journal-title":"Biochim Biophys Acta"},{"issue":"22","key":"10.1016\/j.cll.2014.08.008_bib7","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.2013.280490","article-title":"Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency","volume":"310","author":"Lam","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cll.2014.08.008_bib8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0016-5085(69)80164-2","article-title":"Vitamin B12 uptake by human small bowel homogenate and its enhancement by intrinsic factor","volume":"56","author":"Carmel","year":"1969","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cll.2014.08.008_bib9","series-title":"Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management","author":"Feldman","year":"2002"},{"issue":"Pt 1","key":"10.1016\/j.cll.2014.08.008_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1242\/jeb.203.1.161","article-title":"Analysis of the membrane domain of the gastric H(+)\/K(+)-ATPase","volume":"203","author":"Munson","year":"2000","journal-title":"J\u00a0Exp Biol"},{"key":"10.1016\/j.cll.2014.08.008_bib11","series-title":"Proton pump inhibitors: a balanced view","author":"Chiba","year":"2013"},{"issue":"2","key":"10.1016\/j.cll.2014.08.008_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0016-5085(86)90938-8","article-title":"Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats","volume":"90","author":"Larsson","year":"1986","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cll.2014.08.008_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrd1010","article-title":"A\u00a0proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole","volume":"2","author":"Olbe","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clpt.2005.10.002","article-title":"A\u00a0common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants","volume":"79","author":"Sim","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cll.2014.08.008_bib15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2008.08.045","article-title":"American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cll.2014.08.008_bib16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00424-008-0495-4","article-title":"The gastric HK-ATPase: structure, function, and inhibition","volume":"457","author":"Shin","year":"2009","journal-title":"Pflugers Arch"},{"issue":"7","key":"10.1016\/j.cll.2014.08.008_bib17","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1053\/j.gastro.2008.03.006","article-title":"Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers","volume":"134","author":"Laine","year":"2008","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.cll.2014.08.008_bib18","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1023\/A:1018827003641","article-title":"Effect of omeprazole 40 mg once daily on intraduodenal and intragastric pH in H. pylori-negative healthy subjects","volume":"42","author":"Gan","year":"1997","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.cll.2014.08.008_bib19","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s10620-010-1479-8","article-title":"Impact of acid suppression on upper gastrointestinal pH and motility","volume":"56","author":"Michalek","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cll.2014.08.008_bib20","unstructured":"IMS Health. Top-Line Market Data. Available at: http:\/\/www.imshealth.com\/portal\/site\/ims\/menuitem.5ad1c081663fdf9b41d84b903208c22a\/?vgnextoid=fbc65890d33ee210VgnVCM10000071812ca2RCRD. Accessed March 23, 2014."},{"issue":"Suppl 2","key":"10.1016\/j.cll.2014.08.008_bib21","first-page":"S27","article-title":"Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected]","volume":"104","author":"Heidelbaugh","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.cll.2014.08.008_bib22","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1365-2036.2005.02454.x","article-title":"Long-term use of acid suppression started inappropriately during hospitalization","volume":"21","author":"Zink","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"7156","key":"10.1016\/j.cll.2014.08.008_bib23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.317.7156.452","article-title":"Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database","volume":"317","author":"Bashford","year":"1998","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.cll.2014.08.008_bib24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/j.gastro.2010.08.023","article-title":"Safety of proton pump inhibitor exposure","volume":"139","author":"Yang","year":"2010","journal-title":"Gastroenterology"},{"issue":"17","key":"10.1016\/j.cll.2014.08.008_bib25","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMc066308","article-title":"Proton-pump inhibitors and hypomagnesemic hypoparathyroidism","volume":"355","author":"Epstein","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cll.2014.08.008_bib26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/jcph.316","article-title":"The association of proton pump inhibitors and hypomagnesemia in the community setting","volume":"54","author":"Markovits","year":"2014","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2174\/138920009787048392","article-title":"The effect of proton pump inhibitors on the human microbiota","volume":"10","author":"Vesper","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.cll.2014.08.008_bib28","first-page":"123","article-title":"Properties and function of the P type ion pumps cloned from Helicobacter pylori","volume":"643","author":"Melchers","year":"1998","journal-title":"Acta Physiol Scand Suppl"},{"issue":"19","key":"10.1016\/j.cll.2014.08.008_bib29","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1128\/JB.183.19.5709-5717.2001","article-title":"Genome of the bacterium Streptococcus pneumoniae strain R6","volume":"183","author":"Hoskins","year":"2001","journal-title":"J\u00a0Bacteriol"},{"issue":"3","key":"10.1016\/j.cll.2014.08.008_bib30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cll.2014.08.008_bib31","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/j.gastro.2008.08.044","article-title":"American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cll.2014.08.008_bib32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ajg.2013.71","article-title":"ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE)","volume":"108","author":"Dellon","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cgh.2006.09.016","article-title":"Time trends of gastroesophageal reflux disease: a systematic review","volume":"5","author":"El-Serag","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cll.2014.08.008_bib34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/dji024","article-title":"The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence","volume":"97","author":"Pohl","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1572-0241.2003.07186.x","article-title":"Who is using chronic acid suppression therapy and why?","volume":"98","author":"Jacobson","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cll.2014.08.008_bib36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/j.gastro.2009.04.046","article-title":"Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome","volume":"137","author":"Yang","year":"2009","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.cll.2014.08.008_bib37","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1158\/1078-0432.CCR-11-0934","article-title":"Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus","volume":"18","author":"Yang","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib38","doi-asserted-by":"crossref","first-page":"G32","DOI":"10.1152\/ajpgi.2001.280.1.G32","article-title":"Inducible and neuronal nitric oxide synthase involvement in lipopolysaccharide-induced sphincteric dysfunction","volume":"280","author":"Fan","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"10.1016\/j.cll.2014.08.008_bib39","doi-asserted-by":"crossref","first-page":"G1360","DOI":"10.1152\/ajpgi.00168.2002","article-title":"Downregulation of nNOS and synthesis of PGs associated with endotoxin-induced delay in gastric emptying","volume":"283","author":"Calatayud","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cll.2014.08.008_bib40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2334-13-130","article-title":"Characterization of bacterial biota in the distal esophagus of Japanese patients with reflux esophagitis and Barrett's esophagus","volume":"13","author":"Liu","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cll.2014.08.008_bib41","article-title":"Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors","author":"Amir","year":"2013","journal-title":"Environ Microbiol"},{"issue":"5","key":"10.1016\/j.cll.2014.08.008_bib42","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1053\/j.gastro.2011.07.043","article-title":"Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome","volume":"141","author":"Rajilic-Stojanovic","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cll.2014.08.008_bib43","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ajg.2008.37","article-title":"Helicobacter pylori infection and Barrett's esophagus: a systematic review and meta-analysis","volume":"104","author":"Wang","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.cll.2014.08.008_bib44","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.cgh.2007.08.010","article-title":"Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis","volume":"5","author":"Rokkas","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cll.2014.08.008_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ajg.2013.443","article-title":"Association between Helicobacter pylori and Barrett's esophagus: a case-control study","volume":"109","author":"Fischbach","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cll.2014.08.008_bib46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/AAC.35.3.490","article-title":"Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori","volume":"35","author":"Iwahi","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.cll.2014.08.008_bib47","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","article-title":"American College of Gastroenterology guideline on the management of Helicobacter pylori infection","volume":"102","author":"Chey","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cll.2014.08.008_bib48","doi-asserted-by":"crossref","first-page":"e2836","DOI":"10.1371\/journal.pone.0002836","article-title":"Comparative analysis of human gut microbiota by barcoded pyrosequencing","volume":"3","author":"Andersson","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cll.2014.08.008_bib49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2036.2001.00888.x","article-title":"Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa","volume":"15","author":"Sanduleanu","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.cll.2014.08.008_bib50","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1053\/gast.1996.v110.pm8608881","article-title":"Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer","volume":"110","author":"Labenz","year":"1996","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bpg.2013.03.016","article-title":"Helicobacter pylori and the gastric microbiota","volume":"27","author":"Engstrand","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1590\/S1807-59322007000100008","article-title":"Digestive tract microbiota in healthy volunteers","volume":"62","author":"Zilberstein","year":"2007","journal-title":"Clinics (Sao Paulo)"},{"issue":"11","key":"10.1016\/j.cll.2014.08.008_bib53","doi-asserted-by":"crossref","first-page":"e7985","DOI":"10.1371\/journal.pone.0007985","article-title":"Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use","volume":"4","author":"Li","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cll.2014.08.008_bib54","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1053\/j.gastro.2009.01.073","article-title":"Helicobacter pylori in health and disease","volume":"136","author":"Cover","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2036.1998.00275.x","article-title":"Drug-induced hypochlorhydria causes high duodenal bacterial counts in the elderly","volume":"12","author":"Pereira","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cll.2014.08.008_bib56","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1053\/j.gastro.2005.03.037","article-title":"Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers","volume":"128","author":"Houghton","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cll.2014.08.008_bib57","first-page":"1","article-title":"IARC working group on the evaluation of carcinogenic risks to humans: some industrial chemicals. Lyon, 15-22 February 1994","volume":"60","year":"1994","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"issue":"2","key":"10.1016\/j.cll.2014.08.008_bib58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.291.2.187","article-title":"Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.cll.2014.08.008_bib59","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/jnci\/djs003","article-title":"Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality","volume":"104","author":"Ma","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.cll.2014.08.008_bib60","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection\u2013the Maastricht IV\/Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cll.2014.08.008_bib61","first-page":"211","article-title":"Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection","volume":"14","author":"Liu","year":"2013","journal-title":"J\u00a0Dig Dis"},{"issue":"Pt 4","key":"10.1016\/j.cll.2014.08.008_bib62","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1099\/jmm.0.007302-0","article-title":"Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls","volume":"58","author":"Dicksved","year":"2009","journal-title":"J\u00a0Med Microbiol"},{"issue":"3","key":"10.1016\/j.cll.2014.08.008_bib63","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1128\/AEM.01675-06","article-title":"Chronic Helicobacter pylori infection does not significantly alter the microbiota of the murine stomach","volume":"73","author":"Tan","year":"2007","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib64","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0016-5085(00)70412-4","article-title":"Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer","volume":"118","author":"Wang","year":"2000","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib65","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.gastro.2010.09.048","article-title":"Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia","volume":"140","author":"Lofgren","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib66","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/gutjnl-2013-305178","article-title":"Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis","volume":"63","author":"Lertpiriyapong","year":"2014","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cll.2014.08.008_bib67","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0016-5085(00)70135-1","article-title":"Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa","volume":"118","author":"Klinkenberg-Knol","year":"2000","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cll.2014.08.008_bib68","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","article-title":"Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy","volume":"8","author":"Lombardo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cll.2014.08.008_bib69","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s10620-012-2033-7","article-title":"The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome","volume":"57","author":"Pyleris","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.cll.2014.08.008_bib70","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","article-title":"Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis","volume":"11","author":"Lo","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"24","key":"10.1016\/j.cll.2014.08.008_bib71","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3748\/wjg.v16.i24.2978","article-title":"Small intestinal bacterial overgrowth syndrome","volume":"16","author":"Bures","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2006.02707.x","article-title":"Review article: proton pump inhibitors and bacterial overgrowth","volume":"23","author":"Williams","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cll.2014.08.008_bib73","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1053\/j.gastro.2011.06.075","article-title":"Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis","volume":"141","author":"Wallace","year":"2011","journal-title":"Gastroenterology"},{"issue":"Pt 12","key":"10.1016\/j.cll.2014.08.008_bib74","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1099\/jmm.0.47410-0","article-title":"Imbalance in the composition of the duodenal microbiota of children with coeliac disease","volume":"56","author":"Nadal","year":"2007","journal-title":"J\u00a0Med Microbiol"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib75","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.dld.2013.08.128","article-title":"Use of proton pump inhibitors and subsequent risk of celiac disease","volume":"46","author":"Lebwohl","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"12","key":"10.1016\/j.cll.2014.08.008_bib76","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/aje\/kwt234","article-title":"Decreased risk of celiac disease in patients with Helicobacter pylori colonization","volume":"178","author":"Lebwohl","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.cll.2014.08.008_bib77","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gut.2007.137539","article-title":"Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses","volume":"57","author":"Robinson","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cll.2014.08.008_bib78","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-micro-090110-102830","article-title":"The human gut microbiome: ecology and recent evolutionary changes","volume":"65","author":"Walter","year":"2011","journal-title":"Annu Rev Microbiol"},{"issue":"2","key":"10.1016\/j.cll.2014.08.008_bib79","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cell.2006.08.043","article-title":"Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection","volume":"127","author":"Rawls","year":"2006","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.cll.2014.08.008_bib80","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis","volume":"107","author":"Kwok","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cll.2014.08.008_bib81","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2012.179","article-title":"Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis","volume":"107","author":"Janarthanan","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"23","key":"10.1016\/j.cll.2014.08.008_bib82","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","article-title":"Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease","volume":"294","author":"Dial","year":"2005","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.cll.2014.08.008_bib83","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1503\/cmaj.060284","article-title":"Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy","volume":"175","author":"Dial","year":"2006","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib84","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1503\/cmaj.1040876","article-title":"Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies","volume":"171","author":"Dial","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.cll.2014.08.008_bib85","doi-asserted-by":"crossref","first-page":"696.e11","DOI":"10.1016\/j.jcrc.2014.03.002","article-title":"Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea","volume":"29","author":"Buendgens","year":"2014","journal-title":"J\u00a0Crit Care"},{"issue":"14","key":"10.1016\/j.cll.2014.08.008_bib86","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamainternmed.2013.7056","article-title":"Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011","volume":"173","author":"Chitnis","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1016\/j.cll.2014.08.008_bib87","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1128\/AAC.01506-05","article-title":"In\u00a0vitro killing of nosocomial pathogens by acid and acidified nitrite","volume":"50","author":"Rao","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.cll.2014.08.008_bib88","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/infdis\/151.2.355","article-title":"Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster","volume":"151","author":"Wilson","year":"1985","journal-title":"J\u00a0Infect Dis"},{"issue":"18","key":"10.1016\/j.cll.2014.08.008_bib89","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile\u2013more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.cll.2014.08.008_bib90","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1128\/JCM.43.11.5588-5592.2005","article-title":"Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge","volume":"43","author":"De La Cochetiere","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"issue":"10","key":"10.1016\/j.cll.2014.08.008_bib91","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s10620-012-2315-0","article-title":"Is use of PPIs related to increased intraepithelial lymphocytes in the colon?","volume":"57","author":"Yu","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.cll.2014.08.008_bib92","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00042737-200305000-00021","article-title":"Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity","volume":"15","author":"Poullis","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Pt 2","key":"10.1016\/j.cll.2014.08.008_bib93","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1113\/jphysiol.1996.sp021398","article-title":"Active potassium transport across guinea-pig distal colon: action of secretagogues","volume":"493","author":"Rechkemmer","year":"1996","journal-title":"J\u00a0Physiol"},{"issue":"11","key":"10.1016\/j.cll.2014.08.008_bib94","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/ajg.2013.333","article-title":"Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients","volume":"108","author":"Freedberg","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.cll.2014.08.008_bib95","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archinternmed.2010.73","article-title":"Proton pump inhibitors and risk for recurrent Clostridium difficile infection","volume":"170","author":"Linsky","year":"2010","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.cll.2014.08.008_bib96","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1086\/657319","article-title":"Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease","volume":"202","author":"Manges","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.cll.2014.08.008_bib97","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2049-2618-1-18","article-title":"Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection","volume":"1","author":"Vincent","year":"2013","journal-title":"Microbiome"},{"issue":"3","key":"10.1016\/j.cll.2014.08.008_bib98","doi-asserted-by":"crossref","first-page":"e9836","DOI":"10.1371\/journal.pone.0009836","article-title":"Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome","volume":"5","author":"Jakobsson","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cll.2014.08.008_bib99","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1574-6941.2012.01331.x","article-title":"Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs","volume":"80","author":"Garcia-Mazcorro","year":"2012","journal-title":"FEMS Microbiol Ecol"},{"issue":"4","key":"10.1016\/j.cll.2014.08.008_bib100","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbrc.2009.02.109","article-title":"Gastric acid reduction leads to an alteration in lower intestinal microflora","volume":"381","author":"Kanno","year":"2009","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271214000833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271214000833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:12:49Z","timestamp":1778631169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271214000833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0272271214000833"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2014.08.008","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Proton Pump Inhibitors on the Human Gastrointestinal Microbiome","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2014.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}